TrialPsychiatry and clinical neurosciences2020

Double-blind, placebo-controlled study of lurasidone monotherapy for the treatment of bipolar I depression.

Tadafumi Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.